aTYR PHARMA INC Balance Sheet
ATYR|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
aTYR PHARMA INC had $93M in total assets and $67M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.7M | $11.1M | $10.0M | $2.3M | $17.0M | $17.0M | $9.2M |
| Current Assets | $80.2M | $82.0M | $103.0M | $80.9M | $113.6M | $35.5M | $31.9M |
| PP&E (Net) | $4.3M | $4.8M | $5.5M | $3.1M | $543.0K | $899.0K | $1.3M |
| Total Assets | $93.0M | $96.8M | $120.7M | $95.8M | $115.5M | $38.7M | $36.2M |
| Current Liabilities | $15.1M | $15.0M | $16.4M | $13.9M | $6.0M | $5.9M | $12.9M |
| Shareholders' Equity | $67.5M | $70.0M | $90.7M | $71.5M | $109.3M | $31.6M | $64.2M |